vs
Orthofix Medical Inc.（OFIX）与TaskUs, Inc.（TASK）财务数据对比。点击上方公司名可切换其他公司
TaskUs, Inc.的季度营收约是Orthofix Medical Inc.的1.4倍（$313.0M vs $219.9M），TaskUs, Inc.净利率更高（9.5% vs -1.0%，领先10.5%），TaskUs, Inc.同比增速更快（14.1% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $9.9M），过去两年TaskUs, Inc.的营收复合增速更高（17.3% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CTG（Computer Task Group）是一家总部位于美国纽约布法罗的跨国信息技术人力资源服务企业，为客户提供IT领域的人才配置相关服务。2023年12月，官方宣布Cegeka完成收购该公司74%的多数股权。
OFIX vs TASK — 直观对比
营收规模更大
TASK
是对方的1.4倍
$219.9M
营收增速更快
TASK
高出12.1%
2.0%
净利率更高
TASK
高出10.5%
-1.0%
自由现金流更多
OFIX
多$6.9M
$9.9M
两年增速更快
TASK
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $313.0M |
| 净利润 | $-2.2M | $29.7M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 12.2% |
| 净利率 | -1.0% | 9.5% |
| 营收同比 | 2.0% | 14.1% |
| 净利润同比 | 92.4% | 235.3% |
| 每股收益（稀释后） | $-0.05 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXTASK
| Q4 25 | $219.9M | $313.0M | ||
| Q3 25 | $205.6M | $298.7M | ||
| Q2 25 | $203.1M | $294.1M | ||
| Q1 25 | $193.6M | $277.8M | ||
| Q4 24 | $215.7M | $274.2M | ||
| Q3 24 | $196.6M | $255.3M | ||
| Q2 24 | $198.6M | $237.9M | ||
| Q1 24 | $188.6M | $227.5M |
净利润OFIXTASK
| Q4 25 | $-2.2M | $29.7M | ||
| Q3 25 | $-22.8M | $31.4M | ||
| Q2 25 | $-14.1M | $20.0M | ||
| Q1 25 | $-53.1M | $21.1M | ||
| Q4 24 | $-29.1M | $8.9M | ||
| Q3 24 | $-27.4M | $12.7M | ||
| Q2 24 | $-33.4M | $12.6M | ||
| Q1 24 | $-36.0M | $11.7M |
毛利率OFIXTASK
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXTASK
| Q4 25 | 0.2% | 12.2% | ||
| Q3 25 | -8.3% | 12.7% | ||
| Q2 25 | -7.9% | 10.3% | ||
| Q1 25 | -25.2% | 12.3% | ||
| Q4 24 | -5.3% | 8.0% | ||
| Q3 24 | -9.6% | 9.5% | ||
| Q2 24 | -12.5% | 9.5% | ||
| Q1 24 | -15.6% | 10.4% |
净利率OFIXTASK
| Q4 25 | -1.0% | 9.5% | ||
| Q3 25 | -11.1% | 10.5% | ||
| Q2 25 | -6.9% | 6.8% | ||
| Q1 25 | -27.4% | 7.6% | ||
| Q4 24 | -13.5% | 3.2% | ||
| Q3 24 | -13.9% | 5.0% | ||
| Q2 24 | -16.8% | 5.3% | ||
| Q1 24 | -19.1% | 5.1% |
每股收益（稀释后）OFIXTASK
| Q4 25 | $-0.05 | $0.31 | ||
| Q3 25 | $-0.57 | $0.34 | ||
| Q2 25 | $-0.36 | $0.22 | ||
| Q1 25 | $-1.35 | $0.23 | ||
| Q4 24 | $-0.76 | $0.09 | ||
| Q3 24 | $-0.71 | $0.14 | ||
| Q2 24 | $-0.88 | $0.14 | ||
| Q1 24 | $-0.95 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $211.7M |
| 总债务越低越好 | — | $241.4M |
| 股东权益账面价值 | $450.0M | $600.0M |
| 总资产 | $850.6M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势，按日历期对齐
现金及短期投资OFIXTASK
| Q4 25 | $82.0M | $211.7M | ||
| Q3 25 | $62.9M | $210.0M | ||
| Q2 25 | $65.6M | $181.9M | ||
| Q1 25 | $58.0M | $196.9M | ||
| Q4 24 | $83.2M | $192.2M | ||
| Q3 24 | $30.1M | $180.4M | ||
| Q2 24 | $26.4M | $171.1M | ||
| Q1 24 | $27.0M | $165.3M |
总债务OFIXTASK
| Q4 25 | — | $241.4M | ||
| Q3 25 | $157.2M | $246.3M | ||
| Q2 25 | $157.0M | $249.6M | ||
| Q1 25 | $156.9M | $252.9M | ||
| Q4 24 | $157.0M | $256.2M | ||
| Q3 24 | $118.5M | $259.4M | ||
| Q2 24 | $118.0M | $261.0M | ||
| Q1 24 | $118.2M | $262.6M |
股东权益OFIXTASK
| Q4 25 | $450.0M | $600.0M | ||
| Q3 25 | $442.5M | $567.5M | ||
| Q2 25 | $458.3M | $544.5M | ||
| Q1 25 | $458.3M | $520.3M | ||
| Q4 24 | $503.1M | $496.9M | ||
| Q3 24 | $525.9M | $489.8M | ||
| Q2 24 | $546.0M | $460.2M | ||
| Q1 24 | $570.3M | $454.6M |
总资产OFIXTASK
| Q4 25 | $850.6M | $1.1B | ||
| Q3 25 | $832.6M | $1.0B | ||
| Q2 25 | $837.2M | $1.0B | ||
| Q1 25 | $823.1M | $985.5M | ||
| Q4 24 | $893.3M | $953.3M | ||
| Q3 24 | $867.9M | $942.1M | ||
| Q2 24 | $882.0M | $886.1M | ||
| Q1 24 | $906.0M | $874.5M |
负债/权益比OFIXTASK
| Q4 25 | — | 0.40× | ||
| Q3 25 | 0.36× | 0.43× | ||
| Q2 25 | 0.34× | 0.46× | ||
| Q1 25 | 0.34× | 0.49× | ||
| Q4 24 | 0.31× | 0.52× | ||
| Q3 24 | 0.23× | 0.53× | ||
| Q2 24 | 0.22× | 0.57× | ||
| Q1 24 | 0.21× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $29.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $9.9M |
| 自由现金流率自由现金流/营收 | 7.6% | 3.2% |
| 资本支出强度资本支出/营收 | 4.9% | 6.3% |
| 现金转化率经营现金流/净利润 | — | 1.00× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $73.7M |
8季度趋势，按日历期对齐
经营现金流OFIXTASK
| Q4 25 | $27.7M | $29.7M | ||
| Q3 25 | $12.4M | $54.3M | ||
| Q2 25 | $11.6M | $17.0M | ||
| Q1 25 | $-18.4M | $36.3M | ||
| Q4 24 | $23.7M | $40.7M | ||
| Q3 24 | $11.7M | $17.0M | ||
| Q2 24 | $9.0M | $30.0M | ||
| Q1 24 | $-18.6M | $51.2M |
自由现金流OFIXTASK
| Q4 25 | $16.8M | $9.9M | ||
| Q3 25 | $2.5M | $42.0M | ||
| Q2 25 | $4.5M | $38.0K | ||
| Q1 25 | $-25.1M | $21.8M | ||
| Q4 24 | $15.2M | $20.4M | ||
| Q3 24 | $6.3M | $6.3M | ||
| Q2 24 | $-360.0K | $25.5M | ||
| Q1 24 | $-29.1M | $47.6M |
自由现金流率OFIXTASK
| Q4 25 | 7.6% | 3.2% | ||
| Q3 25 | 1.2% | 14.0% | ||
| Q2 25 | 2.2% | 0.0% | ||
| Q1 25 | -13.0% | 7.8% | ||
| Q4 24 | 7.0% | 7.4% | ||
| Q3 24 | 3.2% | 2.5% | ||
| Q2 24 | -0.2% | 10.7% | ||
| Q1 24 | -15.4% | 20.9% |
资本支出强度OFIXTASK
| Q4 25 | 4.9% | 6.3% | ||
| Q3 25 | 4.8% | 4.1% | ||
| Q2 25 | 3.5% | 5.8% | ||
| Q1 25 | 3.5% | 5.2% | ||
| Q4 24 | 4.0% | 7.4% | ||
| Q3 24 | 2.7% | 4.2% | ||
| Q2 24 | 4.7% | 1.9% | ||
| Q1 24 | 5.6% | 1.6% |
现金转化率OFIXTASK
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 1.72× | ||
| Q4 24 | — | 4.59× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 2.38× | ||
| Q1 24 | — | 4.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
TASK
| Digital Customer Experience | $172.7M | 55% |
| Trust And Safety | $82.7M | 26% |
| AI Services | $57.5M | 18% |
